At a Glance
| 2-FMA | 2-Aminoindane | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 15–30 mg | 10–20 mg |
| Total Duration | 3.3–5.7 hrs | 0.2–0.5 hrs |
| Routes | insufflatedoral | oral |
2-FMA, a Stimulants, and 2-Aminoindane, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 23 documented effects in common, with 28 effects unique to 2-FMA and 4 unique to 2-Aminoindane. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 2-FMA | 2-Aminoindane | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 15–30 mg | 10–20 mg |
| Total Duration | 3.3–5.7 hrs | 0.2–0.5 hrs |
| Routes | insufflatedoral | oral |
| Effects | 51 documented | 27 documented |
| Level | 2-FMA | 2-Aminoindane |
|---|---|---|
| Threshold | 5 mg | 3 mg |
| Light | 5–15 mg | 5–10 mg |
| Common | 15–30 mg | 10–20 mg |
| Strong | 30–50 mg | 20–40 mg |
| Heavy | 50 mg | 40 mg |
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 5–15 mg |
| Common | 15–30 mg |
| Strong | 30–50 mg |
| Heavy | 50 mg |
2-FMA
2-Aminoindane
No direct interaction data available between these substances. This does not mean the combination is safe.